
Value-based contracts among pharmaceutical manufacturers and payers have not achieved the success levels necessary to drive significant systemic change.

Value-based contracts among pharmaceutical manufacturers and payers have not achieved the success levels necessary to drive significant systemic change.

Building a durable specialty pharmacy organization requires more than URAC accreditation and pharmacists.

Published: July 26th 2017 | Updated:

Published: September 11th 2017 | Updated: